FDA.reportPublic FDA data

Linzess 145 MCG Oral Capsule

RxCUI
1307415
RxNorm name
Linzess 145 MCG Oral Capsule
Display name
Linzess 145 MCG Oral Capsule
Full name
Linzess 145 MCG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
09beda19-56d6-4a56-afdc-9a77b70b2ef3Linzess 145 MCG Oral Capsule [PSN] · linaclotide 0.145 MG Oral Capsule [Linzess] [SBD] · Linzess 0.145 MG Oral Capsule [SY] · Linzess 145 MCG Oral Capsule [SY]439These highlights do not include all the information needed to use LINZESS safely and effectively. See full prescribing information for LINZESS . LINZESS ® ( linaclotide ) capsules, for oral use Initial U.S. Approval: 201220260521